Reuters logo
BRIEF-Actinium Pharmaceuticals receives clearance from Health Canada to initiate pivotal phase 3 sierra trial of Iomab-B
May 10, 2017 / 11:15 AM / 7 months ago

BRIEF-Actinium Pharmaceuticals receives clearance from Health Canada to initiate pivotal phase 3 sierra trial of Iomab-B

May 10 (Reuters) - Actinium Pharmaceuticals Inc

* Actinium Pharmaceuticals receives clearance from Health Canada to initiate pivotal phase 3 sierra trial of Iomab-B Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below